Tag Archives: Short

U.S. FDA Approves ALK’s Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Children and Adolescents With Short Ragweed Pollen-Induced Allergic Rhinitis With or Without Conjunctivitis

ROUND ROCK, Texas, April 19, 2021 /PRNewswire/ — ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of allergies, announced that the U.S. Food and Drug Administration (FDA) approved Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use for the… Read More: U.S. FDA Approves ALK’s Ragwitek (Short Ragweed Pollen Allergen Extract)… »

Short Bouts Of Exercise Can Make You Smarter, Study Finds

We don’t need to tell you that exercise (no matter the duration or intensity) comes with a plethora of health benefits—but as this latest study also suggests, it can, in fact, work to improve brain function. As covered on Science Daily, Neuroscientists at OHSU in Portland, Oregon, have discovered that a short burst of exercise… Read More: Short Bouts Of Exercise Can Make You Smarter, Study Finds »

How Short Fingers and Low Testosterone Make You Vulnerable

Read the Full Article for Free! Subscribe to the #1 Natural Health Newsletter Unlock censored health information that Google doesn’t want you to read Keep your privacy secure — We are no longer active on Facebook and will soon be blocking our content from Google search to ensure your privacy stays protected Get access to… Read More: How Short Fingers and Low Testosterone Make You Vulnerable »

WCLC: Roche’s Tecentriq comes up short in squamous lung cancer, leaving Merck’s Keytruda ‘unchallenged’

Roche has been hoping its Tecentriq could put up the kind of life-lengthening numbers in squamous non-small cell lung cancer (NSCLC) that could help it compete with Merck’s Keytruda—but no dice. The Swiss drugmaker Tuesday unveiled results showing that its Tecentriq-chemo combo failed to outdo solo chemo at extending the lives of previously untreated patients.… Read More: WCLC: Roche’s Tecentriq comes up short in squamous lung cancer,… »